Improvement in the plasma omega-3 index by the use of a fish oil-enriched spread

Annals of Nutrition and Metabolism

Volumn 53, Issue 1, 2008, Pages 23-28

  De Groote, Guy ^a   De Laporte, André ^b   Dhondt, Goedele ^b   Christophe, Armand ^c,d  

^a BARC CRI Laboratories   (Belgium)

^b R and D Center   (Belgium)

^c GHENT UNIVERSITY   (Belgium)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Docosahexaenoic acid; Eicosapentaenoic acid; Fish oil enriched spread; Omega 3 index

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; MARGARINE; PHOSPHOLIPID; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIETARY INTAKE; ELEMENTAL DIET; ERYTHROCYTE; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; HUMAN EXPERIMENT; LIPID COMPOSITION; MALE; NORMAL HUMAN; PHOSPHOLIPID BLOOD LEVEL; PILOT STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; STUDENT T TEST;

ADULT; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; FOOD, FORTIFIED; HUMANS; LINEAR MODELS; MALE; PHOSPHOLIPIDS; PILOT PROJECTS;

EID: 50849085744     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000152870     Document Type: Article

References (22)

1. Harris WS: Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor. Pharmacol Res 2007;55:217-223.
2. von Schacky C: Omega-3 fatty acids and cardiovascular disease. Curr Opin Clin Nutr Metab Care 2007;10:129-135.
3. Geppert J, Kraft V, Demmelmair H, Koletzko B: Docosahexaenoic acid supplementation in vegetarians effectively increases omega-3 index: a randomized trial. Lipids 2005;40:807-814.
4. Katan MB, van Birgelen A, Deslypere JP, Penders M, van Staveren WA: Biological markers of dietary intake, with emphasis on fatty acids. Ann Nutr Metab 1991;35:249-252.
5. Skeaff CM, Hodson L, McKenzie JE: Dietary-induced changes in fatty acid composition of human plasma, platelet, and erythrocyte lipids follow a similar time course. J Nutr 2006;136:565-569.
6. Cao J, Schwichtenberg KA, Hanson NQ, Tsai MY: Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids. Clin Chem 2006;52:2265-2272.
7. Lepage G, Roy CC: Direct transesterification of all classes of lipids in a one step reaction. J Lipid Res 1986;27:114-120.
8. Christophe AB, Matthijs F: New method for the determination of the fatty acid pattern of serum lipid classes. Clin Chim Acta 1967;16:39-43.
9. De Vriese SR, Christophe AB, Maes M: Lowered serum n-3 polyunsaturated fatty acid (PUFA) levels predict the occurrence of postpartum depression: further evidence that lowered n-3 PUFAs are related to major depression. Life Sci 2003;73:3181-3187.
10. Christophe AB, Robberecht E, Franckx H, De-Baets F, Van-de-Pas M: Effect of administration of gamma-linolenic acid on the fatty acid composition of serum phospholipids and cholesteryl esters in patients with cystic fibrosis. Ann Nutr Metab 1994;38:40-47.
11. Schoonjans F, Zalata A, Depuydt CE, Comhaire FH: MedCalc: a new computer program for medical statistics. Comput Methods Programs Biomed 1995;48:257-262.
12. Murphy KJ, Meyer BJ, Mori T, Burke V, Mansour J, Patch CS, Trapsell LC, Noakes M, Clifton PA, Barden A, Puddey IB, Beilin LJ, Howe PR: Impact of foods enriched with n-3 long-chain polyunsaturated fatty acids on erythrocyte n-3 levels and cardiovascular risk factors. Br J Nutr 2007;97:749-759.
13. Harris WS, von Schacky C: The omega-3 index: a new risk factor for death from coronary heart disease? Prev Med 2004;39:212-220.
14. von Schacky C, Harris WS: Cardiovascular risk and the omega-3 index. J Cardiovasc Med 2007;8(suppl 1):S46-S49.
15. Hoge Gezondheidsraad. Voedingsaanbevelingen voor België. Herziening November 2006. HGR#7145-2. www.health.fgov.be/CSH_HGR.
16. Harris WF, Sands SA, Windsor SL, Ali HA, Stevens TL, Magalski A, Porter CB, Borkon AM: Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and responses to supplementation. Circulation 2004;110:1645-1649 (erratum published in Circulation 2004;110:3156).
17. Harris WS, Reid KJ, Sands SA, Spertus JA: Blood omega-3 and trans fatty acids in middle aged acute coronary syndrome patients. Am J Cardiol 2007;99:154-158.
18. Katan MB, Deslypere JP, van Biggelen AP, Penders M, Zegwaard M: Kinetics of incorporation of dietary fatty acids into serum cholesteryl esters, erythrocyte membranes, and adipose tissue: an 18 month controlled study. J Lipid Res 1997;38:2012-2022.
19. Subbaiah PV, Kaufman D, Bagdade JD: Incorporation of dietary n-3 fatty acids into molecular species of phosphatidyl choline and cholesteryl ester in normal human plasma. Am J Clin Nutr 1993;58:360-368.
20. Albert CM, Campos H, Stampfer MJ, Ridker PM, Manson JE, Willett WC, Ma J: Blood levels of long chain n-3 fatty acids and the risk of sudden death. N Eng J Med 2002;346:1113-1118.
21. Harris WS, Dirienzo MA, Sands SA, Jones PG, Eapen AK: Stearidonic acid increases the red blood cell and heart eicosapentaenoic acid content in dogs. Lipid 2007;42:325-333.
22. Hussein N, Ah-Sing E, Wilkingson P, Leach C, Griffin BA, Milward DJ: Long-chain conversion of [13C] linoleic acid and alpha-linolenic acid in response to marked changes in their dietary intake in men. J Lipid Res 2005;46:269-280.